当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析

泓博医药

(301230)

  

流通市值:40.59亿  总市值:45.10亿
流通股本:1.26亿   总股本:1.40亿

泓博医药(301230)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.35亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益102618.29万元,未分配利润13883.66万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产130554.41万元,负债27936.12万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入514,401,151.54352,738,072.83169,429,129.41544,471,262.04
营业总成本484,120,946.96329,746,732.17157,965,262.18553,727,749.83
其他经营收益
营业利润32,017,358.5122,744,651.5311,119,439.093,633,016.2
利润总额31,825,220.4522,677,172.9111,059,785.943,535,116.37
净利润34,749,579.2624,761,426.2711,973,873.8217,083,154.83
每股收益
其他综合收益-79,436.07-112,334.74-81,158.6964,923.15
综合收益总额34,670,143.1924,649,091.5311,892,715.1317,148,077.98
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计562,877,685.5618,934,271.92584,490,479.58554,317,975.45
非流动资产:
非流动资产合计742,666,439.86737,651,658.01746,779,546762,108,412.74
资产总计1,305,544,125.361,356,585,929.931,331,270,025.581,316,426,388.19
流动负债:
流动负债合计138,007,757.07149,623,885.8134,091,501.45125,397,520.57
非流动负债:
非流动负债合计141,353,423.12146,798,435.93150,934,307.26158,331,409.82
负债合计279,361,180.19296,422,321.73285,025,808.71283,728,930.39
所有者权益(或股东权益):
归属于母公司股东权益合计1,026,182,945.171,060,163,608.21,046,244,216.871,032,697,457.8
股东权益合计1,026,182,945.171,060,163,608.21,046,244,216.871,032,697,457.8
负债和股东权益合计1,305,544,125.361,356,585,929.931,331,270,025.581,316,426,388.19
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计451,715,185.39281,252,796.67128,078,776.98539,351,247.7
经营活动现金流出小计369,200,872.98241,826,667.93129,955,084.88458,487,717.95
经营活动产生的现金流量净额82,514,312.4139,426,128.74-1,876,307.980,863,529.75
投资活动产生的现金流量:
投资活动现金流入小计20,105,380.5320,105,380.5310,059,178.08622,973,363.97
投资活动现金流出小计53,694,584.7127,276,315.216,339,135.58667,795,592.82
投资活动产生的现金流量净额-33,589,204.18-7,170,934.67-6,279,957.5-44,822,228.85
筹资活动产生的现金流量:
筹资活动现金流入小计25,664,755.5820,664,755.587,653,171.3419,654,670.89
筹资活动现金流出小计81,683,294.5123,924,858.96,321,483.55157,260,798.68
筹资活动产生的现金流量净额-56,018,538.93-3,260,103.321,331,687.79-137,606,127.79
汇率变动对现金及现金等价物的影响2,251,028.462,110,7281,322,735.544,816,818.38
现金及现金等价物净增加额-4,842,402.2431,105,818.75-5,501,842.07-96,748,008.51
期末现金及现金等价物余额33,906,544.9369,854,765.9233,247,105.138,748,947.17
补充资料:
现金及现金等价物的净增加额-31,105,818.75--96,748,008.51
最新报告期:2025-10-30
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋周豫,张崴0.330.460.712025-10-30
开源证券汪晋,余汝意0.430.590.822025-09-02
太平洋周豫,张崴0.430.621.002025-08-28
TOP↑